CIK: 0001634557
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PRTA | Prothena Corporation plc | Stock-Other | 33.74% | — | -0.45% | |
| 2 | ALKS | Alkermes plc | Stock-Healthcare | 17.12% | — | -4.08% | |
| 3 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 16.83% | -71.30% | EXIT | |
| 4 | ABBV | Abbvie INC | Stock-Healthcare | 15.81% | — | -67.31% | |
| 5 | GILD | Gilead Sciences INC | Stock-Healthcare | 6.19% | — | -24.98% | |
| 6 | BIIB | Biogen INC | Stock-Healthcare | 5.18% | — | -2.32% | |
| 7 | ✓ | Bioverativ Inc | Stock-Other | 5.14% | — | -0.88% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PRTA | Prothena Corporation plc | +11.1% | -0.45% | Trim |
| 2 | BIIB | Biogen INC | +1.5% | -2.32% | Trim |
| 3 | TBPH | Theravance Biopharma, Inc. | +1.2% | -0.00% | Trim |
| 4 | ALKS | Alkermes plc | +0.8% | -4.08% | Trim |
| 5 | ✓ | Bioverativ Inc | +0.8% | -0.88% | Trim |
| 6 | GILD | Gilead Sciences INC | +0.4% | -24.98% | Trim |
| 7 | ABBV | Abbvie INC | -15.8% | -67.31% | Trim |